The group found that TRT offered slight improvements in sexual and erectile function; they found no other benefits. Eisenberg says that studies on TRT. Oral testosterone is a less common type of TRT that is more expensive and less practical. Long-term use may cause liver damage. While TRT offers benefits to people with low testosterone levels, it can cause many short-term side effects.
Some physical changes that TRT can cause include increased muscle mass and bone density and decreased body weight. In some studies, a relationship was found between TRT and increased blood pressure, while in others, no effect was seen or a relationship was observed with a decrease in blood pressure. During the time you're taking TRT, your body stops producing testosterone, so you'll want to give it time to produce its own male hormone again. However, doctors don't usually recommend TRT as a first course of action for low testosterone levels, even for men who show these symptoms.
Prostate cancer needs testosterone to grow, so administering TRT can cause cancer cells to grow faster. A study is currently under way to evaluate the long-term cardiovascular outcomes of people receiving TRT. Research recommends that doctors be careful when prescribing TRT to people who have severe obstructive sleep apnea. People with a history of osteoporosis or fractures from low trauma will have a bone density scan one to two years after starting treatment with TRT.
The Food and Drug Administration (FDA) explains that the benefits and safety of TRT to treat low testosterone levels caused by aging are unknown.
Testosterone replacement
therapy (TRT) involves an injection, patch, or gel of the hormone testosterone to bring the level back to normal. As a result, only people who can't use other forms of TRT turn to oral testosterone. Millions of American men use a prescription testosterone injection or gel as a form of testosterone replacement therapy (often referred to as TRT therapy) to restore normal levels of the male hormone.The researchers found that, in 92 patients (61%), the effects of TRT did not continue, but they did in the remaining 59 patients (39%). However, more recent studies have failed to link TRT to increased cardiovascular events, at least over a two-year treatment period, and, in fact, it may protect against the development of diabetes in some men.
